tiprankstipranks
Mayne Pharma Group (MAYNF)
OTHER OTC:MAYNF
US Market
MAYNF
Mayne Pharma Group
RESEARCH TOOLSreports

Mayne Pharma Group (MAYNF) Ratios

24 Followers

Mayne Pharma Group Ratios

MAYNF's free cash flow for Q4 2026 was AU$0.49. For the 2026 fiscal year, MAYNF's free cash flow was decreased by AU$ and operating cash flow was AU$-0.16. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 1.31 1.31 1.35 1.47 1.78
Quick Ratio
 1.09 1.09 1.16 1.23 1.51
Cash Ratio
 0.32 0.32 0.23 0.35 0.33
Solvency Ratio
 0.17 0.17 -0.05 -0.15 0.30
Operating Cash Flow Ratio
 0.06 0.06 0.07 -0.05 -0.14
Short-Term Operating Cash Flow Coverage
 0.38 0.38 0.50 -4.01 -3.99
Net Current Asset Value
AU$ -179.03MAU$ -179.03MAU$ -291.53MAU$ -228.40MAU$ -60.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.04 0.03 0.04
Debt-to-Equity Ratio
 0.11 0.11 0.11 0.09 0.07
Debt-to-Capital Ratio
 0.10 0.10 0.10 0.08 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.07 0.04
Financial Leverage Ratio
 2.33 2.33 2.74 2.52 1.97
Debt Service Coverage Ratio
 0.08 0.53 0.88 -11.20 -11.36
Interest Coverage Ratio
 -10.47 -6.46 -4.71 -29.58 -17.83
Debt to Market Cap
 0.17 0.19 0.09 0.10 0.11
Interest Debt Per Share
 0.60 0.61 0.58 0.55 0.71
Net Debt to EBITDA
 -4.80 -1.33 -0.44 0.61 0.28
Profitability Margins
Gross Profit Margin
49.62%50.10%60.59%56.30%14.62%
EBIT Margin
-14.48%-8.94%-5.40%-47.76%-141.21%
EBITDA Margin
2.12%7.66%10.31%-30.12%-105.57%
Operating Profit Margin
-14.48%-8.94%-5.78%-35.83%-101.56%
Pretax Profit Margin
9.32%9.32%-20.41%-48.97%-146.91%
Net Profit Margin
6.38%6.38%-22.99%-44.89%63.87%
Continuous Operations Profit Margin
8.13%8.13%-22.07%-43.44%-172.91%
Net Income Per EBT
68.44%68.44%112.65%91.66%-43.47%
EBT Per EBIT
-64.38%-104.30%353.05%136.69%144.65%
Return on Assets (ROA)
2.69%2.69%-9.25%-15.24%9.39%
Return on Equity (ROE)
6.58%6.26%-25.34%-38.36%18.48%
Return on Capital Employed (ROCE)
-8.55%-5.28%-3.13%-16.77%-19.89%
Return on Invested Capital (ROIC)
-7.01%-4.33%-2.98%-14.74%-19.59%
Return on Tangible Assets
5.48%5.48%-19.86%-30.32%18.59%
Earnings Yield
9.97%10.97%-23.71%-47.16%32.80%
Efficiency Ratios
Receivables Turnover
 2.18 2.18 2.48 2.01 0.88
Payables Turnover
 7.65 7.58 5.32 8.13 4.89
Inventory Turnover
 3.48 3.45 3.18 2.27 1.90
Fixed Asset Turnover
 6.96 6.96 6.93 7.28 3.57
Asset Turnover
 0.42 0.42 0.40 0.34 0.15
Working Capital Turnover Ratio
 4.70 4.48 3.42 1.99 2.94
Cash Conversion Cycle
 224.17 224.71 193.33 297.37 534.55
Days of Sales Outstanding
 167.08 167.08 147.24 181.70 416.56
Days of Inventory Outstanding
 104.79 105.79 114.75 160.59 192.57
Days of Payables Outstanding
 47.71 48.16 68.66 44.92 74.58
Operating Cycle
 271.87 272.87 261.99 342.29 609.13
Cash Flow Ratios
Operating Cash Flow Per Share
 0.19 0.20 0.22 -0.19 -0.53
Free Cash Flow Per Share
 0.16 0.16 0.07 -0.45 -3.23
CapEx Per Share
 0.04 0.04 0.16 0.26 2.70
Free Cash Flow to Operating Cash Flow
 0.81 0.81 0.30 2.36 6.09
Dividend Paid and CapEx Coverage Ratio
 5.30 5.30 1.42 -0.73 -0.16
Capital Expenditure Coverage Ratio
 5.30 5.30 1.42 -0.73 -0.20
Operating Cash Flow Coverage Ratio
 0.36 0.36 0.42 -0.39 -0.91
Operating Cash Flow to Sales Ratio
 0.04 0.04 0.04 -0.04 -0.23
Free Cash Flow Yield
5.17%5.68%1.31%-9.79%-73.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.68 9.00 -4.39 -2.12 3.05
Price-to-Sales (P/S) Ratio
 0.64 0.58 0.97 0.95 1.95
Price-to-Book (P/B) Ratio
 0.62 0.57 1.07 0.81 0.56
Price-to-Free Cash Flow (P/FCF) Ratio
 19.23 17.60 76.20 -10.22 -1.36
Price-to-Operating Cash Flow Ratio
 15.61 14.28 22.65 -24.15 -8.29
Price-to-Earnings Growth (PEG) Ratio
 0.07 -0.07 0.09 0.05 0.25
Price-to-Fair Value
 0.62 0.57 1.07 0.81 0.56
Enterprise Value Multiple
 25.15 6.26 8.96 -2.55 -1.56
Enterprise Value
 206.31M 183.99M 377.13M 298.19M 303.27M
EV to EBITDA
 25.35 6.26 8.96 -2.55 -1.56
EV to Sales
 0.54 0.48 0.92 0.77 1.65
EV to Free Cash Flow
 16.28 14.52 72.62 -8.25 -1.15
EV to Operating Cash Flow
 13.21 11.78 21.59 -19.49 -7.03
Tangible Book Value Per Share
 -0.89 -0.90 -2.17 -1.44 0.21
Shareholders’ Equity Per Share
 4.81 4.89 4.68 5.70 7.81
Tax and Other Ratios
Effective Tax Rate
 0.13 0.13 -0.08 0.11 -0.18
Revenue Per Share
 4.72 4.80 5.16 4.88 2.26
Net Income Per Share
 0.30 0.31 -1.19 -2.19 1.44
Tax Burden
 0.68 0.68 1.13 0.92 -0.43
Interest Burden
 -0.64 -1.04 3.78 1.03 1.04
Research & Development to Revenue
 0.05 0.05 0.05 0.05 0.09
SG&A to Revenue
 0.59 0.54 0.62 0.14 0.32
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.01 0.04
Income Quality
 0.50 0.50 -0.19 0.09 0.14
Currency in AUD